HC Wainwright Has Positive Outlook for KROS Q1 Earnings
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – HC Wainwright upped their Q1 2025 EPS estimates for Keros Therapeutics in a research report issued on Thursday, February 27th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of ($1.27) per share for the quarter, up from their prior estimate of ($1.51). […]
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – HC Wainwright upped their Q1 2025 EPS estimates for Keros Therapeutics in a research report issued on Thursday, February 27th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of ($1.27) per share for the quarter, up from their prior estimate of ($1.51). […]
